Agarase AgaCA233 as well as mutant and application thereof
By mining and modifying the GH16 family's β-agaenase AgaCA233 from the Catenovulum agarivorans DS-2 genome, the problem of poor thermal stability of agaenase was solved, and industrialized production of high-efficiency agarooligosaccharides was achieved, reducing costs and increasing Product specificity and stability.
Patent Information
- Application Number
- CN202411157070.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-26
- Estimated Expiration
- 2044-08-22
AI Technical Summary
The thermal stability of existing agarose enzymes is poor, which affects the agarose degradation efficiency. In addition, traditional degradation methods have problems such as high cost, environmental pollution and product active groups destruction, making it difficult to achieve efficient and low-cost industrial production of agarose oligosaccharides.
The β-agaCA233 of the GH16 family was mined from the Catenovulum agarivorans DS-2 genome, and its mutants were constructed through genetic engineering technology to improve its thermal stability and catalytic activity, and applied to the industrial production of agar enzymatic method.
It significantly improves the thermal stability and catalytic activity of agarase, realizes the production of highly efficient agarose oligosaccharides, reduces production costs, simplifies the production process, and improves the specificity and stability of the product.
Smart Images

Figure CN119020326A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of microbial enzymes, and in particular relates to agarase AgaCA233, a mutant thereof and application thereof. Background Art
[0002] Agar has high gel strength and hydrophilicity, can absorb water and swell, and has special stabilizing effects and compatibility. It is widely used as a thickener, emulsifier, gelling agent, stabilizer, excipient, moisture retainer and other additives. Agar macromolecules with high polymerization degree can be degraded into agar oligosaccharides with low polymerization degree under the action of agarase. Agar oligosaccharides are functional oligosaccharides that can be used as prebiotics to increase the relative abundance of probiotics such as Lactobacillus and Bifidobacterium in the intestinal flora of animals, thereby promoting animal growth and improving animal immunity. In addition, agar oligosaccharides also have a variety of biological activities such as inhibiting the growth of pathogens; inhibiting the growth of colon cancer cells; reducing fasting blood sugar levels; anti-oxidation; anti-aging, and repairing liver damage. Therefore, the use of agar to develop high-value-added agar oligosaccharides is of great significance and economic value.
[0003] To realize the large-scale industrial utilization of agar oligosaccharides, an efficient, low-cost and green degradation method is urgently needed. At present, the commonly used degradation methods of agarose are chemical degradation, physical degradation and biodegradation. Chemical degradation, as a traditional means of industrial preparation of oligosaccharides, covers a variety of methods such as alkaline hydrolysis, acid hydrolysis, oxidative degradation and combined degradation. Among them, although the acid hydrolysis method is low in cost and easy to operate, it can only achieve the initial degradation of agarose under normal pressure conditions, and produces more by-products, which increases the difficulty of extraction and separation, and is easy to cause environmental pollution and irreversible damage to the active groups of polysaccharides. Physical degradation methods, such as radiation, ultrasonic and pyrolysis, have attracted attention for their simple operation, fast degradation rate and high preparation rate. However, this type of method can usually only change the size of polysaccharide molecules without changing their structure, so the specificity, specificity and stability are poor. Enzymatic hydrolysis is more gentle and environmentally friendly. The use of enzymatic hydrolysis in the industrial production of oligosaccharides can improve production efficiency, simplify the production process, increase product activity and recovery rate, etc. Agarase, as an enzyme that can catalyze the degradation of agarose, belongs to five different glycoside hydrolase families, namely GH16, GH50, GH86, GH117 and GH118. According to the type of glycosidic bond it cleaves in agarose, agarase plays a key role in the green biodegradation of agarose.
[0004] At present, agarase of the GH16 family is one of the most widely studied enzymes. This family has many members, but their thermal stability shows significant differences. In the GH16 family, the optimum temperature of most agarases is around 40-50°C. On the other hand, studies have shown that the catalytic efficiency of agarase in liquid agarose solution is significantly better than that in the gel state, which may be related to the freer movement of molecules in the liquid and the smaller specific surface area of the gel state. However, agarose solution can only present a fluid state at high temperature (≥50°C), which makes the thermal stability of agarase a key factor affecting the degradation efficiency of agarose. Exploring and modifying high-temperature resistant agarases has become the key to the high value-added utilization of agar and obtaining agar oligosaccharides with high purity and a specific degree of polymerization. It is a core issue that needs to be solved urgently. Summary of the invention
[0005] In view of the deficiencies in the prior art, the object of the present invention is to provide an agarase with good thermal stability, a mutant thereof and applications thereof.
[0006] In a first aspect of the present invention, an agarase AgaCA233 is provided.
[0007] In another preferred embodiment, the amino acid sequence of the agarase is an amino acid sequence having more than 95% homology with the amino acid sequence shown in SEQ ID NO.1, preferably 96% homology, more preferably 97%, 98%, 99% or 100% homology, and has the ability to catalyze the decomposition of agarose.
[0008] In another preferred embodiment, the amino acid sequence of the agarase is shown as SEQ ID NO.1.
[0009] In the second aspect of the present invention, a biomaterial related to the agarase described in the first aspect of the present invention is provided, wherein the biomaterial comprises at least one of the following 1)-5):
[0010] 1) The gene encoding the agarase according to the first aspect of the present invention;
[0011] 2) an expression cassette containing the coding gene described in 1);
[0012] 3) a recombinant vector containing the coding gene described in 1);
[0013] 4) A recombinant microorganism containing the coding gene described in 1);
[0014] 5) A recombinant microorganism containing the recombinant vector described in 3).
[0015] Further preferably, in 1), the nucleotide sequence of the encoding gene is a nucleotide sequence having more than 95% homology with the nucleotide sequence shown in SEQ ID NO.2, preferably 96% homology, more preferably 97%, 98%, 99% or 100% homology.
[0016] Further preferably, in said 1), the nucleotide sequence of the coding gene is as shown in SEQ ID NO.2;
[0017] More preferably, in 3), the recombinant vector uses pET-28a(+) vector as an expression vector.
[0018] More preferably, in 4) or 5), the recombinant microorganism is recombinant Escherichia coli BL21 (DE3).
[0019] In the third aspect of the present invention, there is provided use of the agarase according to the first aspect of the present invention in the decomposition of agar or agarose and the production of agar-oligosaccharides.
[0020] In the fourth aspect of the present invention, a mutant of the agarase described in the first aspect of the present invention is provided, which has higher catalytic activity and higher thermal stability than the wild type.
[0021] In another preferred embodiment, the amino acid sequence of the agarase mutant has more than 95% homology with the amino acid sequence shown in SEQ ID NO.3, preferably 96% homology, more preferably 97%, 98%, 99% or 100% homology, and has higher catalytic activity and higher thermal stability than the wild type.
[0022] In another preferred embodiment, the amino acid sequence of the agarase mutant is shown in SEQ ID NO.3.
[0023] In the fifth aspect of the present invention, a biological material related to the mutant of agarase according to the fourth aspect of the present invention is provided, wherein the biological material comprises at least one of the following 1)-5):
[0024] 1) A gene encoding the mutant of agarase according to the fourth aspect of the present invention;
[0025] 2) an expression cassette containing the coding gene described in 1);
[0026] 3) a recombinant vector containing the coding gene described in 1);
[0027] 4) A recombinant microorganism containing the coding gene described in 1);
[0028] 5) A recombinant microorganism containing the recombinant vector described in 3).
[0029] Further preferably, in 1), the nucleotide sequence of the encoding gene is a nucleotide sequence having more than 95% homology with the nucleotide sequence shown in SEQ ID NO.4, preferably 96% homology, more preferably 97%, 98%, 99% or 100% homology.
[0030] Further preferably, in 1), the nucleotide sequence of the encoding gene is as shown in SEQ ID NO.4.
[0031] More preferably, in 3), the recombinant vector uses pET-28a(+) vector as an expression vector.
[0032] More preferably, in 4) or 5), the recombinant microorganism is recombinant Escherichia coli BL21 (DE3).
[0033] In the sixth aspect of the present invention, there is provided use of the mutant of agarase according to the fourth aspect of the present invention in the decomposition of agar or agarose and the production of agar-oligosaccharide.
[0034] It should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, they will not be described one by one here.
[0035] Compared with the prior art, the present invention has the following advantages and progress:
[0036] The present invention mines a β-agarase of the GH16 family from the genome information of Catenovulum agarivorans DS-2 through bioinformatics technology, named AgaCA233, which has high catalytic activity and thermal stability, and can be efficiently applied to the production of industrial preparation of agar oligosaccharides. In addition, the present invention uses genetic engineering technology to truncate the above-mentioned agarase AgaCA233, and a pair of complementary sequence primers in opposite directions are designed, and a high-fidelity DNA polymerase is used for amplification, and only a part of the gene is amplified to construct a truncated recombinant DNA molecule, and finally a agarase AgaCA233 mutant is constructed. The thermal stability and catalytic activity of the agarase AgaCA233 mutant of the present invention are greatly improved compared with the wild-type AgaCA233, and it is one of the most stable agarases of the GH16 family at present, and it is a new type of agarase with great potential, which can be applied to the enzymatic industrial production of agar oligosaccharides, thereby promoting a substantial reduction in the production cost of agar oligosaccharides. BRIEF DESCRIPTION OF THE DRAWINGS
[0037] The accompanying drawings, which constitute a part of the present invention, are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their descriptions are used to explain the present invention and do not constitute improper limitations on the present invention.
[0038] Figure 1 : Electrophoresis of recombinant plasmid. M:Standard protein marker; 1:Recombinant plasmid of AgaCA233 mutant.
[0039] Figure 2 : SDS-PAGE analysis of AgaCA233 mutant and AgaCA233. (a) M: marker; 1: E. coli pET-28a(+) bacterial suspension protein; 2: AgaCA233 mutant crude enzyme; 3: AgaCA233 mutant pure enzyme. (b) M: marker; 1: E. coli pET-28a(+) bacterial suspension protein; 2: AgaCA233 crude enzyme; 3: AgaCA233 pure enzyme.
[0040] Figure 3 :Effect of temperature on the enzyme activity of AgaCA233 and AgaCA233 mutants.
[0041] Figure 4 : Comparative analysis of specific enzyme activity of AgaCA233 mutants and AgaCA233.
[0042] Figure 5 :Comparative analysis of the thermal stability of AgaCA233 and AgaCA233 mutants at 50℃ and 60℃. (a) 50℃. (b) 60℃. DETAILED DESCRIPTION
[0043] The present invention provides an agarase AgaCA233, a mutant thereof and an application thereof. The present invention is specifically described below in conjunction with the embodiments to facilitate further understanding of the present invention by those skilled in the art. However, the embodiments described below are only a part of the embodiments of the present invention and should not be regarded as any form of limitation to the present invention. It should be pointed out that adjustments and improvements made by those of ordinary skill in the art based on the concept of the present invention should be regarded as the scope of protection of the present invention. The specific technical operation steps and operators are not indicated in the embodiments, and are carried out in accordance with the general technical conditions described in the literature of the field or the relevant product instructions.
[0044] Example 1 Construction of recombinant expression plasmid of agarase AgaCA233
[0045] From the genome information of Catenovulum agarivorans DS-2, a β-agarase of the GH16 family was mined through bioinformatics technology and named AgaCA233. According to the gene sequence of agarase agaca233, NcoI and XhoI restriction sites were added at both ends, and then synthesized by a gene company according to the method of chemical total synthesis. Then, it was connected with the pET-28a(+) expression vector linearized by double restriction enzymes to construct the recombinant expression plasmid pET-28a(+)-agaca233 of agarase AgaCA233, which was transferred into Escherichia coli Top10 for amplification. After the plasmid was extracted, it was verified to be completely correct by sequencing.
[0046] Wild-type agarase AgaCA233 amino acid sequence:
[0047] ADWDGVPIPAPAGQNKTWQILSISDDFNYAASPNNKPSAFTSRWNDSYINAWKGPGDTEFSSGHSYTNSGKLALQAAEKPGTDKVYAGIISSKQTFTYPLYIEAR AKSTNNTMANAVWMLSADSTQELDAMEAYGSDRPGQEWFDRRMHVSHHVFIREPFQDYQPKDAGSWIYNNEEPWRVAYHNYGMHWKDPWNVDYYYIDGVLVRSVSG QQMIDPHNYTNGTGVNKPLHIIIDMEHQDWRDVKPTPAELADPARSIFYVDWIRVYKPVDSSASAPTPPTSATSLKARHSNKCIDLAAGNSANGTNMQQWNCSAT NTNQDITFVAKGGGYYEMKTKHNKCIDVAGKATANGANLVQWNCYNGTNQQFKLLDKGNGWFQLQAKHSGKCLEIANSATTNGANLQQWGCGNGNNQQWKFQ(SEQ ID NO.1).
[0048] Wild-type agarase agaca233 gene DNA sequence:
[0049]
[0050] Example 2 Construction of AgaCA233 mutant recombinant expression plasmid
[0051] Using pET-28a(+)-agaca233 as a template, primers F(-cbm) and R(-cbm) were used to perform PCR amplification of the mutant gene AgaCA233m according to the following reaction system and reaction conditions.
[0052] Primer sequences for amplifying the agarase AgaCA233 mutant gene AgaCA233m:
[0053] F(-cbm):TTTAAGAAGGAGATATACCATGGGC;
[0054] R(-cbm):
[0055] TGGTGGTGGTGGTGGTGCTCGAGTTTATAAACACGGATCCAATCTACA T.
[0056] Table 1. PCR reaction system
[0057]
[0058] Table 2. PCR reaction process
[0059]
[0060]
[0061] The target gene AgaCA233m fragment amplified by the PCR was connected to the plasmid pET-28a(+) linearized by double restriction enzyme digestion (NcoI and XhoI), and the target gene and the linearized vector were connected according to the connection system in Table 3 to obtain the AgaCA233 mutant recombinant expression plasmid pET-28a(+)-AgaCA233m.
[0062] Agarase AgaCA233 mutant amino acid sequence:
[0063] ADWDGVPIPAPAGQNKTWQILSISDDFNYAASPNNKPSAFTSRWNDSYINAWKGPGDTEFSSGHSYTNSGKLALQAAEKPGTDKVYAGIISSKQTFTYPLYIEARAKSTNNTMANAVWMLSADSTQELDAMEAYGSDRPGQEWFDRRMHVSHHVFIREPFQDYQPKDAGSWIYNNEEPWRVAYHNYGMHWKDPWNVDYYIDGVLVRSVSGQQMIDPHNYTNGTGVNKPLHIIIDMEHQDWRDVKPTPAELADPARSIFYVDWIRVYK(SEQ ID NO.3).
[0064] DNA sequence of the mutant gene of agarase AgaCA233m:
[0065] GCAGACTGGGATGGCGTACCTATTCCAGCACCAGCAGGTCAAAACAAAACTTGGCAAATTCTATCTATTTCAGATGACTTTAACTACGCAGCTTCACCAAATAACAAACCAAGCGCTTTTACTAGCCGTTGGAACGACAGCTACATTAATGCTTGGAAAGGGCCGGGCGATACAGAGTTTAGCTCAGGTCACTCGTACACCAATTCTGGTAAATTAGCTTTACAGGCGGCTGAAAAACCAGGCACAGACAAAGTTTACGCAGGTATTATTTCTTCAAAACAAACATTTACTTATCCGCTTTATATTGAAGCGCGGGCCAAATCAACCAACAATACTATGGCCAATGCGGTGTGGATGTTAAGTGCCGATTCCACCCAAGAATTAGATGCTATGGAAGCTTACGGGAGTGACAGACCAGGCCAAGAGTGGTTTGATCGCCGCATGCATGTGAGCCACCACGTATTTATTCGCGAACCATTCCAAGACTATCAACCAAAGGATGCAGGTTCTTGGATATACAATAATGAAGAGCCATGGCGCGTTGCTTATCATAACTATGGTATGCACTGGAAAGATCCTTGGAATGTTGATTATTATATTGACGGCGTGTTGGTTAGAAGTGTTTCAGGCCAGCAAATGATTGATCCACATAATTACACCAATGGCACTGGCGTGAATAAACCTTTGCACATTATTATTGATATGGAACATCAAGATTGGCGTGATGTTAAACCAACACCAGCCGAACTAGCCGATCCTGCCAGAAGCATTTTTTATGTAGATTGGATCCGTGTTTATAAA(SEQ ID NO.4).
[0066] Table 3. Ligation system of the target gene and the vector
[0067]
[0068] The ligation products were detected by 1% agarose gel electrophoresis, and the results were as follows Figure 1As shown, the results showed that the target band was in the range of 5000-7500bp, the target band was about 6500bp, the bands were consistent, and the recombinant expression plasmid containing the AgaCA233 mutant was obtained.
[0069] Example 3 Inducible expression of agarase AgaCA233 and AgaCA233 mutants in Escherichia coli
[0070] The plasmids pET-28a(+)-agaca233 and pET-28a(+)-AgaCA233m were transformed into competent cells of E. coli BL21(DE3) according to the following method to obtain AgaCA233 and AgaCA233 mutant engineering strains E. coli BL21(DE3) / pET-28a(+)-agaca233 and E. coli BL21(DE3) / pET-28a(+)-AgaCA233m. The specific steps are:
[0071] (1) Take 5 μL of recombinant plasmid sample and add it to 50-100 μL of competent cells, mix slowly and place on ice for 30 min.
[0072] (2) Heat shock for 90 seconds (42°C water bath), then quickly return to the ice bath and wait for 3 to 5 minutes.
[0073] (3) Add 500 μL LB liquid culture medium (without antibiotics), mix gently, and culture with shaking for 1 h (37°C).
[0074] (4) Centrifuge the bacterial solution (5000 rpm, 1 min) to precipitate the bacteria and aspirate most of the supernatant (about 50-100 μL of the remaining resuspended bacteria).
[0075] (5) Spread the bacterial solution evenly on LB plates (containing Kana antibiotics) and culture in a 37°C incubator overnight.
[0076] (6) Pick a single colony on the LB plate and culture it. Take 50 μL of the bacterial solution and send it for testing to determine whether the recombinant strain is correct.
[0077] The successfully constructed genetically engineered strains E.coli BL21(DE3) / pET-28a(+)-agaca233 and E.coli BL21(DE3) / pET-28a(+)-AgaCA233m were inoculated into 5mL LB medium and cultured on a shaker for 12h (37°C, 220rpm) as seed solution. 200μL of seed solution was inoculated into 200mL LB medium (containing Kana), and after shaking culture for 2h (37°C, 220rpm), 200μL IPTG (0.5M) was added at a ratio of 1‰, and shaken culture was performed for 20-24h (16°C, 220rpm) to induce the expression of the target protein. The cells were collected and the supernatant was discarded after centrifugation. Add 15mL lysis buffer (Tris 20mM, NaCl 20mM, DTT 1mM, imidazole 20mM, pH 7.0) to the bacteria, place on an ice-water mixture for ultrasonic disruption (power 260-300W, total disruption time 30min, working time 3s, interval time 3s). After the end of the ultrasound, centrifuge again (4°C, 8000rpm) for 40min, and the resulting supernatant is the crude enzyme solution. The crude enzyme solution is purified by using a nickel column His Trap TM HP-5mL for recombinant enzyme AgaCA233 and AgaCA233 mutants. Add 5×SDS loading buffer to the enzyme solution, mix well, boil for 10min, then centrifuge at 12000rpm for 10min, and perform SDS-PAGE protein electrophoresis on the supernatant with 5% concentrated gel and 12% separation gel.
[0078] The results are as follows Figure 2 As shown, compared with the empty bacteria E. coli pET-28a(+) control group, the genetically engineered strains E. coli BL21(DE3) / pET-28a(+)-agaca233 and E. coli BL21(DE3) / pET-28a(+)-AgaCA233m had overexpressed protein bands in the supernatant after ultrasonic disruption after induction. The overexpressed protein sizes were approximately 50 kD and 30 kD, respectively, which were consistent with expectations, indicating that the overexpression of agarase AgaCA233 and AgaCA233 mutants in E. coli was successfully achieved, and the expression was soluble.
[0079] Example 4 Catalytic activity and thermal stability of agarase AgaCA233 and AgaCA233 mutants
[0080] (1) Determination of the optimal temperature of the enzyme
[0081] Add 270 μL of agarose solution (concentration of 0.25%) to a 1.5 mL EP tube and keep it in an electric thermostatic water bath at 40, 50, 60, 70, 80°C and 90°C for 10 min, then add 30 μL of enzyme reaction for 20 min, then add 300 μL of 3,5-dinitrosalicylic acid and boil for 7 min to terminate the reaction, use an enzyme reader to measure the OD value of the reaction solution at 540 nm, calculate the relative enzyme activity according to the enzyme activity determination method, and determine the optimal temperature for the enzymatic reaction.
[0082] The results of the optimal temperature experiment of AgaCA233 and AgaCA233 mutants showed that AgaCA233 could catalyze the decomposition of agarose to produce reducing sugars at a temperature of 40-80°C, and 60°C was its optimal temperature. However, when the temperature was higher than 80°C, the enzyme activity of AgaCA233 was almost lost. The experimental results showed that the AgaCA233 mutant had high enzyme activity in the temperature range of 40-100°C. Figure 3 The optimum temperature is shown to be 80°C, from which it can be seen that the catalytic stability of the AgaCA233 mutant at high temperature is significantly improved compared with the wild type.
[0083] (2) Determination of enzyme activity and evaluation of agar degradation ability
[0084] The AgaCA233 mutant and AgaCA233 enzymes were diluted to 0.0003 mg mL -1 ,0.003mg·mL -1 The OD value at 540nm was measured by DNS method and converted to the amount of galactose. We define the amount of enzyme required to hydrolyze agarose to produce 1mg galactose per unit time (per minute) as one enzyme activity unit U. By calculation, it can be found that the enzyme activities of AgaCA233 mutant and AgaCA233 are 0.046U and 0.0221U respectively. Using origin software to draw a graph, the relative enzyme activity relationship between the two can be obtained as follows Figure 4 It can be clearly seen that the specific enzyme activity of the AgaCA233 mutant is 19.45 times higher, which significantly improves the ability of agarase to catalyze the decomposition of agarose.
[0085] (3) Study on temperature stability
[0086] The enzyme solution was kept in a constant temperature water bath at 50°C and 60°C for different periods of time, and then the enzyme activity was measured. The reaction was allowed to proceed for 20 minutes and then boiled for 7 minutes to terminate the reaction. The OD value of the reaction solution at 540 nm was measured using an enzyme marker, and the relative enzyme activity was calculated according to the enzyme activity determination method to determine the temperature stability of the enzymatic reaction.
[0087] The results of the thermal stability experiments of AgaCA233 and AgaCA233 mutants at 50°C and 60°C are shown in Figure 5 As shown: When AgaCA233 was incubated at 50℃ for 180min, its relative enzyme activity only remained about 30%. When the AgaCA233 mutant was incubated at 50℃ for 180min, it still had about 70% relative enzyme activity. When the incubation time was increased to 300min, its relative enzyme activity was still higher than 50%. At 60℃, when AgaCA233 was incubated for 10min, it still had about 50% relative enzyme activity. When the incubation time was increased to 60min, its relative enzyme activity was only about 30%. When the AgaCA233 mutant was incubated at 60℃ for 120min, it still had relatively high enzyme activity, and its relative enzyme activity was still higher than 70%. This shows that at 50℃ and 60℃, the thermal stability of the AgaCA233 mutant is better than that of AgaCA233.
[0088] The above is only a preferred embodiment of the present invention and does not limit the present invention in any way. For those skilled in the art, any modification and change made to the above embodiment according to the technical essence of the present invention shall fall within the protection scope of the technical solution of the present invention.
Claims
1. An agarase AgaCA233, characterized in that The amino acid sequence of the agarase has more than 95% homology with the amino acid sequence shown in SEQ ID NO.1, preferably 96% homology, more preferably 97%, 98%, 99% or 100% homology, and has the ability to catalyze the decomposition of agarose.
2. Agarase AgaCA233 according to claim 1, characterized in that The amino acid sequence of the agarase is shown in SEQ ID NO.
1.
3. A biomaterial related to the agarase AgaCA233 according to claim 1 or 2, wherein the biomaterial comprises at least one of the following 1) to 5): 1) A gene encoding agarase according to claim 1 or 2; 2) an expression cassette containing the coding gene described in 1); 3) a recombinant vector containing the coding gene described in 1); 4) A recombinant microorganism containing the coding gene described in 1); 5) A recombinant microorganism containing the recombinant vector described in 3).
4. The biomaterial according to claim 3, characterized in that The nucleotide sequence encoding the gene in 1) is a nucleotide sequence having more than 95% homology with the nucleotide sequence shown in SEQ ID NO.2, preferably 96% homology, more preferably 97%, 98%, 99% or 100% homology.
5. Use of the agarase AgaCA233 according to claim 1 or 2 in agar decomposition and agar-oligosaccharide production.
6. A mutant of agarase AgaCA233 according to claim 1 or 2, characterized in that: The amino acid sequence of the mutant has more than 95% homology with the amino acid sequence shown in SEQ ID NO.3, preferably 96% homology, more preferably 97%, 98%, 99% or 100% homology.
7. The mutant of agarase AgaCA233 according to claim 6, characterized in that The amino acid sequence of the mutant is shown in SEQ ID NO.
3.
8. A biological material related to the mutant of agarase AgaCA233 according to claim 6 or 7, wherein the biological material comprises at least one of the following 1) to 5): 1) A gene encoding a mutant of agarase AgaCA233 according to claim 6 or 7; 2) an expression cassette containing the coding gene described in 1); 3) a recombinant vector containing the coding gene described in 1); 4) A recombinant microorganism containing the coding gene described in 1); 5) A recombinant microorganism containing the recombinant vector described in 3).
9. The biomaterial according to claim 8, characterized in that The nucleotide sequence encoding the gene in 1) is a nucleotide sequence having more than 95% homology with the nucleotide sequence shown in SEQ ID NO.4, preferably 96% homology, more preferably 97%, 98%, 99% or 100% homology.
10. Use of the mutant of agarase AgaCA233 according to claim 6 or 7 in agar decomposition and agar-oligosaccharide production.
Citation Information
Patent Citations
Agarase mutant with improved thermal stability and application thereof
CN114836405A
Agarase mutant as well as coding gene and application thereof
CN114934033A
Apparatus for laundry treatment and method of controlling the same
KR102483851B1
